Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema

QR Code

Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema

Background: Diabetic macular edema (DME) is a leading cause of vision impairment globally among working population, with anti-vascular endothelial growth factor (anti-VEGF) therapies being the standard treatment. The high cost of anti-VEGF drive use of biosimilars like Razumab®. This study provides...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dhandapani A, Ravindran S, Muthusamy K, Muruganandham K, Kaliamurty S
Format:	Article
Language:	English
Published:	KIMS Foundation and Research Center 2025-06-01
Series:	Journal of Medical and Scientific Research
Subjects:	diabetes macular edema vascular endothelial growth factor biosimilar central subfoveal thickness
Online Access:	https://jmsronline.com/archive-article/Ranibizumab-Razumab-diabetic-macular-edema
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long-term outcomes of drusenoid retinal pigment epithelium detachment in eyes with age-related macular degeneration
by: Sinem Karabulut, et al.
Published: (2025-06-01)

Effectiveness and Safety of Intravitreal Brolucizumab for Diabetic Macular Edema After Vitrectomy: A Before-and-After Study at a Specialized Center in Japan
by: Saito K, et al.
Published: (2025-06-01)

Postoperative, or pseudophakic, macular edema
by: I. E. Ioshin
Published: (2020-12-01)

The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
by: A. Zh. Fursova, et al.
Published: (2023-03-01)

OCT Biomarkers in Diagnostic of Uveitic and Radiation-induced Macular Edema
by: I. E. Panova, et al.
Published: (2025-06-01)

OCT Patterns of Macular Edema in Intermediate Uveitis
by: I. E. Panova, et al.
Published: (2024-12-01)

GENETIC CRITERIA FOR ANTI-ANGIOGENIC THERAPY FOR TREATMENT OF DIABETIC MACULAR EDEMA
by: A. Z. Fursova, et al.
Published: (2019-02-01)

Experiences of using Aflibercept in diabetic macular edema treatment: data from routine clinical practice
by: E. Yu. Santoro
Published: (2018-12-01)

Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy
by: Tavonvunchai F, et al.
Published: (2025-06-01)

Aqeuous humor cytokines concentration changes in patients with diabetic macular edema after intravitreal pharmacotherapy
by: A. Zh. Fursova, et al.
Published: (2023-07-01)

Immunological Aspects of Macular Edema after Cataract Surgery in Patients with Diabetes Mellitus
by: M. A. Frolov, et al.
Published: (2019-01-01)

ASSOCIATION BETWEEN THE DEGREE OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
by: Andhika Guna Dharma, et al.
Published: (2022-01-01)

Real-world outcomes and treatment patterns in Colombian patients with neovascular age-related macular degeneration and diabetic macular edema
by: Joshua Kock, et al.
Published: (2025-06-01)

Surgical treatment of diabetic macular edema
by: R. R. Fayzrakhmanov, et al.
Published: (2024-10-01)

The impact of switching from anti-VEGF therapy to dexamethasone intravitreal implant on refractory macular edema in patients with retinal vein occlusion: A systematic review and meta-analysis
by: He-Ping Zhang, et al.
Published: (2025-08-01)

Time-in-Range Analysis of Responses after Intravitreal Dexamethasone Therapy in Eyes with Diabetic Macular Edema
by: Igor Kozak, MD, PhD, et al.
Published: (2025-09-01)

Persistent Diabetic Macular Edema: A Comprehensive Review of Current Treatments and Emerging Therapeutic Options
by: Shahin Faghihi, et al.
Published: (2024-07-01)

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study
by: José Luis Poveda, et al.
Published: (2025-05-01)

Cataract surgery in patients with diabetes mellitus. Prevention and optimisation of the diabetic macular edema therapy
by: A. Zh. Fursova, et al.
Published: (2024-03-01)

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
by: M. M. Bikbov, et al.
Published: (2016-11-01)

Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema
by: Gaixia Zhai, et al.
Published: (2025-06-01)

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions
by: A. G. Shchuko, et al.
Published: (2020-05-01)

Investigation of the Effectiveness of the Combined Treatment of Diabetic Macular Edema
by: S. I. Zakieva, et al.
Published: (2025-03-01)

Features of pathological changes in the retina and vitreoretinal interface in the macular zone in patients with diabetic macular edema
by: E. V. Boiko, et al.
Published: (2021-12-01)

Combined Treatment of Post-Thrombotic Macular Edema with Navigation Laser Coagulation and Intravitreal Administration of Angiogenesis Inhibitors
by: I. A. Krylova, et al.
Published: (2023-04-01)

The Role of Steroids in the Management of Macular Edema from Retinal Vein Occlusion
by: M. V. Budzinskaya, et al.
Published: (2019-03-01)

The Analysis of Risk Factors of Development of Macular Edema after Phacoemulsification
by: V. L. Kokorev
Published: (2019-06-01)

A study of therapeutic effects of 670 nm irradiation in different types of diabetic macular edema
by: S. Ramin, et al.
Published: (2021-02-01)

Patterns of Foveal Eversion in Patients with Diabetic Macular Edema
by: E. Yu. Santoro, et al.
Published: (2025-03-01)

Сlinical, functional and morphological results of diabetic macular edema antiangiogenic treatment in patients with diabetes mellitus type two
by: L. K. Moshetova, et al.
Published: (2014-07-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Macular edema after surgical treatment of rhegmatogenous retinal detachment – the possibilities of its prediction
by: E. V. Boiko, et al.
Published: (2021-12-01)

Serum Apolipoprotein B and B/A1 Ratio as Early Negative Biomarkers for OCT- and OCTA-Detected Retinal Changes in Diabetic Macular Edema
by: Soedarman S, et al.
Published: (2025-07-01)

Сomparative Analysis of the Long-Term Results of Diabetic Macular Edema and Epiretinal Membrane Surgical Treatment
by: M. M. Bikbov, et al.
Published: (2019-04-01)

Development of Clinical and Morphometric Classification of Macular Edema in Retinal Vein Occlusions
by: A. A. Fil, et al.
Published: (2022-07-01)

EFFECT OF COMPLEX TREATMENT USING PLATELET AUTOPLASMA ON CLINICAL AND LABORATORY PARAMETERS OF PATIENTS WITH ENDOGENOUS UVEITIS AND MACULAR EDEMA
by: N. S. Arbeneva, et al.
Published: (2019-11-01)

Macular thickness in patients with pseudoexfoliation syndrome after uneventful phacoemulsification
by: V. V. Potemkin, et al.
Published: (2022-07-01)

Evaluation of anterior scleral thickness in eyes with central serous chorioretinopathy
by: Parvathy Prabhakaran, et al.
Published: (2025-06-01)

Ocular Risk Factors in the Primary Formation of Diabetic Macular Edema in Patients with Type 2 Diabetes Mellitus
by: M. V. Pshenichnov, et al.
Published: (2019-06-01)

Intraocular Risk Factors in the Primary Formation of Diabetic Macular Edema in Patients with Diabetes Mellitus Type II
by: M. V. Pshenichnov, et al.
Published: (2019-03-01)